Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma
<b>Objectives:</b> To assess amide proton transfer weighted (APTw) MR imaging capabilities in differentiating high-grade glial tumors across alpha-thalassemia/mental retardation X-linked (ATRX) expression, tumor-suppressor protein p53 expression (p53), O6-methylguanine-DNA methyltransferase promoter (MGMTp) methylation, isocitrate dehydrogenase (IDH) status, and proliferation marker Ki-67 (Ki-67 index) as a preoperative diagnostic aid. <b>Material & Methods:</b> A total of 42 high-grade glioma WHO grade 4 (HGG) patients were evaluated prospectively (30 males and 12 females). All patients were examined using conventional MRI, including the following: T1w-MPRAGE pre- and post-contrast administration, conventional T2w and 3D FLAIR, and APTw imaging with a 3T MR scanner. Receiver operating characteristic (ROC) curves were calculated for the APTw% mean, median, and max signal for the different molecular biomarkers. A logistic regression model was constructed for combined mean and median APTw% signals for p53 expression. <b>Results:</b> The whole-tumor max APTw% signal could significantly differentiate MGMTp from non-MGMTp HGG, <i>p</i> = 0.035. A cutoff of 4.28% max APTw% signal yielded AUC (area under the curve) = 0.702, with 70.6% sensitivity and 66.7% specificity. The mean/median APTw% signals differed significantly in p53 normal versus p53-overexpressed HGG s: 1.81%/1.83% vs. 1.15%/1.18%, <i>p</i> = 0.002/0.006, respectively. Cutoffs of 1.25%/1.33% for the mean/median APTw% signals yielded AUCs of 0.786/0.757, sensitivities of 76.9%/76.9%, and specificities of 50%/66.2%, <i>p</i> = 0.002/0.006, respectively. A logistic regression model with a combined mean and median APTw% signal for p53 status yielded an AUC = 0.788 and 76.9% sensitivity and 66.2% specificity. ATRX-, IDH- wild type (wt) vs. mutation (mut), and the level of Ki-67 did not differ significantly, but trends were found: IDH-wt and low Ki-67 showed higher mean/median/max APTw% signals vs. IDH-mut and high Ki-67, respectively. ATRX-wt vs. mutation showed higher mean and median APTw% signals but lower max APTw% signal. <b>Conclusions</b>: APTw imaging can potentially be a useful marker for the stratification of p53 expression and MGMT status in high-grade glioma in the preoperative setting and potentially aid surgical decision-making.
Authors
- Linda Knutsson (ORCID: https://orcid.org/0000-0002-4263-113X)
- Patrick Alexander Liebig (ORCID: https://orcid.org/0000-0001-7342-3715)
- Anna Rydelius (ORCID: https://orcid.org/0000-0002-6742-1825)
- Johan Bengzon (ORCID: https://orcid.org/0000-0001-6536-2107)
- Jimmy Lätt (ORCID: https://orcid.org/0000-0003-4715-4157)
- Faris Durmo (ORCID: https://orcid.org/0000-0001-7364-5991)
- Elisabet Englund (ORCID: https://orcid.org/0000-0002-2708-2443)
- Tim Salomonsson (ORCID: https://orcid.org/0000-0002-9219-3617)
- Pia C. Sundgren (ORCID: https://orcid.org/0000-0001-9237-1236)
- Peter C. M. van Zijl
Institutions
- Kennedy Krieger Institute (US)
- Johns Hopkins University (US)
- Lund University (SE)
- Johns Hopkins Medicine (US)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Tomography
- Published
- 2025-05-31
- DOI
- https://doi.org/10.3390/tomography11060064
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- Cancerfonden
- Vetenskapsrådet